From: Long-term clinical efficacy of topical treatment with recombinant human nerve growth factor in neurotrophic keratopathy: a novel cure for a rare degenerative corneal disease?
Stage 2 recurrence
Stage 3 recurrence
End of treatment
(n = 18)
0
12 months
3
24 months
36 months
(n = 10)
1
48 months
(n = 9)